Zuvest
← All research
Latest research ·

JPM JPMorgan Chase & Co.

Financial Services · Banks - Diversified
$327.06
-0.88% on the day · price at time of report
Neutral
CautiousNeutralConstructive

Verdict by horizon

Long-term investing
Hold

The market prices JPM as a premium bank at about 2.5x book. I think that is roughly fair, given the 15.7% ROE, 12.5% revenue CAGR and steady buybacks. It is a quality compounder to own, but with no margin of safety at 327. Add on weakness toward 2.1-2.2x book.

Swing trading
No valid setup

A better entry: a reclaim of 334-338 (EMA10/21) on rising volume, or a pullback to 324-325 holding with a reversal candle for a tighter stop. A clean trend trade needs price above the 50 SMA (338.38).

Day trading
Bias: neutral (not in play)

Price 327.06 vs VWAP 327.62 (below), 6 VWAP crosses and a range-day hint. RVOL 1.29 is under 1.5, so JPM is not in play. The gap was -0.71% with no earnings catalyst today; next earnings are 2027-01-14. 59% of the average daily range is already used (ADR 7.65)

Options
No structure

CHEAP/fair: ATM IV 26.3% (30 DTE) vs HV20 29.4%, IV/HV20 0.89; HV60 21.3%. 30d expected move ±5.96% (307.56-346.56). Term structure normal/flat; put skew 4.9 pts (modest hedging demand). IV rank unknown (no history). Favors buying premium via defined-risk debi

Views by discipline

▤ Fundamentals & valuationneutral · 55
⌕ Accounting quality & eventsnot_applicable · 55
◍ Macro, policy & creditneutral · 55
⟋ Technical analysisneutral · 55
⇄ Positioning & sentimentneutral · 55

Valuation snapshot

Fair value (bear / base / bull)$250.00 / $315.00 / $375.00
Street mean target$373.48
P/E fwd · FCF yield · ROIC12.8 · -17.01% · —

JPMorgan Chase & Co. operates as a bank and financial holding company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia Pacific, Latin America, and the Caribbean. It operates in three segments: Consumer & Community Banking, Commercial & Investment Bank, and Asset & Wealth Management. The company offers deposit, investment and lending products, and cash management; mortgage origination and servicing activities; residential mortgages and home equity loans; and

Charts

Price, indicators & swing plan

Intraday & day-trade plan

Research views

Valuation

Relative strength

Fundamentals

Options

Market backdrop

Research memo

JPM decision memo, 18 Nov 2026

Bottom line

  • Long-term investing: HOLD if you already own it. Do not start a new position at $327.06. JPMorgan is a high-quality bank (quality grade A), but the price already reflects that. The fundamental analyst's base value is about $315, below today's price. Its suggested accumulation zone is $270–295, which is roughly 10–17% below the current price.
  • Swing trading: NO TRADE. the risk review rejected the oversold-bounce plan. Its reward-to-risk was 0.35 to the first target against a required 2.0. Wait for a better entry, described below.
  • Day trading: NO TRADE. Both intraday plans were rejected, with reward-to-risk of 0.82 and 0.38 against a required 1.5. JPM is not "in play" today. The pattern-day-trader rule also limits a $10k margin account.
  • Options: NO TRADE. The smallest sensible defined-risk spread can lose $270. Your per-options cap is $100.
  • Biggest single risk: the market regime. SPY sits only +0.01% above its 200-day average. There have been 8 distribution days in 25 sessions, and VIX is 25.48 in backwardation. A break of SPY's 200-day, or of JPM's own 200-day at $322.83, would likely make a bad situation worse.

Long-term investment view

The business is excellent, but the price is not a bargain. ROE (return on equity, meaning profit per dollar of shareholder capital) is 15.7%, against a cost of equity of about 10.1%. So JPM creates value. Revenue has compounded at 12.5% a year, and the share count fell 6.35% through buybacks. The payout ratio is a modest 26% (/).

Why "hold" rather than "buy": banks are valued on price-to-book (P/B, the price relative to the accounting value of equity), not on a DCF. The negative FCF of −$147.8B reflects balance-sheet flows and is meaningless for a bank. Using ROE of 15.7% and growth of 4–5%, the justified P/B comes out at about 1.9–2.1x. The stock trades at 2.47x, so the market is already paying a premium.

Illustrative scenario math. The fundamental analyst's values are bear $250, base $315 and bull $375. With assumed weights of 25/50/25, the expected value is about $314, roughly 4% below today's price. These weights are my illustration, not analyst output. The result shows there is no margin of safety. Analysts are more optimistic, with a mean target of $373.48 (+14.2%). Their targets span from Citi's Neutral at $350 to Barclays' Overweight at $425.

There is no variant perception here. teaches that being right about a great company is not enough; you must differ from the market and explain why it is wrong. Our view (high-quality, fairly priced) is essentially the consensus view. So the edge is a patience edge: wait for the price to come to you.

Forensics (accounting checks). No red flags appear on the available signals, with a CLEAN verdict at modest confidence. The standard manipulation scores (Beneish, Altman, Piotroski) do not apply to banks. Two items still need reading: - An 8-K Item 5.02 officer change filed 17 Nov. Who left is unknown. - A batch of 424B2 filings on 18 Nov. These are probably structured notes, but that is unverified.

Thesis breakers (written in advance): - Charge-offs and provisions rising while reserve coverage falls. - ROE sliding toward the ~10% cost of equity. - CET1 capital nearing the regulatory minimum, or a cut to capital returns. - Revenue turning negative as net interest income falls.

The biggest data gap: NIM, CET1, ROTCE, NCO ratio and reserve coverage are all unknown. Treat every long-term conclusion above as provisional until you have them.

Swing trading view

Verdict: rejected by the risk review. Stay flat.

What the trading analyst proposed. A speculative RSI(2) bounce, where RSI(2) is a very short-term overbought/oversold gauge. The inputs were RSI(2) at 5.6 (deeply oversold) and the close of $327.06 just above the rising 200-day SMA of $322.83.

Why it was rejected: - The stop needed to sit below the 200-day. - Overhead resistance sits close, at $334.35 and $339.96. - That pairing gives only 0.35R to the first target and about 0.9R to the final target. A swing trade needs 2R or more.

The broader picture confirms caution: - Trend Template: 4 of 8 checks pass. - ADX 16.2, meaning no real trend. - Weinstein stage: 1/3 (basing or topping). - MACD has made a bearish cross. - CMF is −0.187, indicating net distribution. - JPM has lagged its sector by 6.44 points over 3 months.

What a valid swing setup would look like. These are not current plans. They describe conditions that could be re-submitted to the risk review: 1. Pullback that holds. Price dips to $324–325, holds above the 200-day, and prints a reversal candle. That allows a tighter stop and a better reward-to-risk. 2. Strength confirmation. A reclaim of $334–338 (the 10/21-day EMAs and Tenkan line) on rising volume. A clean trend trade would really need price back above the 50-day SMA at $338.38.

Either version still needs 2R or more and reduced size, because the macro analyst's guidance is "reduced."

Bearish watch item. A close below $325.61 or $324.25 would trigger Donchian breakdown signals. A close below $322.83 or $320 would suggest Stage 4 (a downtrend). Shorts are allowed in your profile, but no short plan has been submitted or approved.

Day trading view (today / next session)

Verdict: no trade. Both plans were rejected.

Conditions at 12:28 ET: - Price $327.06, just below VWAP of $327.62. VWAP is the volume-weighted average price, the intraday "fair" line. - 6 VWAP crosses so far, which signals chop. - RVOL (volume relative to normal) of 1.29, below the 1.5 "in play" threshold. - 59% of the average daily range already used.

The two plans: - The VWAP-reclaim long offered 0.82R. - The VWAP-rejection short offered 0.38R, because it was shorting straight into support at $325.61.

Both fall short of the 1.5R minimum (risk rules).

Account constraint. Under $25k in a US margin account, frequent day trades can trigger the pattern-day-trader (PDT) restriction. For this account, a well-built swing usually beats a marginal day trade.

Next session. Treat the prior-day close (PDC) of $329.96, today's low of $325.61 and the 200-day at $322.83 as the reference levels. Only act if JPM becomes "in play" on a real catalyst and offers 1.5R or more.

Options view

No recommendation.

Implied volatility is cheap-to-fair: - ATM IV (the market's expected volatility) is 26.3%. - 20-day realized volatility is 29.4%, giving an IV/HV ratio of 0.89. - The 30-day expected move is ±5.96%, a range of $307.56–346.56. - Earnings are 57 days away, so there is no "IV crush" problem.

In principle, that favors buying defined-risk debit spreads over selling premium.

But the size does not fit. The 325/330 December bull call spread has a $270 maximum loss, against a $50 per-trade budget and a $100 options cap. Every other structure is worse: - Credit spreads and the iron condor risk about $380–390. - A cash-secured put needs $31,500. - Weekly options are illiquid, with spreads around 10.5% of mid.

The lesson: a small account sometimes simply cannot express a view in options on a $327 stock.

Where the analysts disagree

Topic One side Other side Who is stronger, by horizon
Value Analysts: Buy, mean target $373.48 Fundamental: base $315, justified P/B ~2.1x vs 2.47x Investing horizon goes to fundamentals, but with caveats. ROTCE is unknown and likely above ROE, which would justify a higher multiple. The fundamental analyst's g=4% is its own assumption.
Short-term direction Technical: RSI(2) 5.6 oversold, price above a rising 200-day, bounce possible Flow and macro: CMF −0.187, falling OBV, 8 SPY distribution days, VIX backwardation Swing horizon leans to the regime and flow side. Oversold readings in a stressed market can stay oversold (the "falling knife" risk).
Macro for banks A positive curve (10y–3m +0.77pp) supports net interest margin. XLF leads SPY by 3.97 points. CPI 4.08%, a 10-year yield above 5%, and HY spreads widening slightly to 3.43pp Net NEUTRAL. The curve helps earnings while high yields and credit risk cap multiples.
Positioning Institutions net adding (top 10: 6 adding). Short interest is tiny at 0.9%. Only insider sales (3 sales, $3.59M). Bank of America cut its stake 29.5%. Weak signals both ways. 13F data is stale by about 45 days.
Trading analyst vs risk review Trading analyst offered conditional plans risk review rejected all three on reward-to-risk risk review is final.

What to watch next (catalysts, levels, data)

Events and filings - 8-K Item 5.02 (filed 17 Nov): read it now. A surprise CFO or chief risk officer exit would be a warning sign. - 424B2 batch (18 Nov): confirm these are notes, not common-stock issuance. - Q4 earnings on 14 Jan 2027: consensus is EPS $5.86 and revenue $51.07B. The average earnings move is 2.12%, but gaps of about 4% have happened. Focus on charge-offs, reserves, NIM and CET1.

JPM price levels

Level Meaning
$324.36 / $322.83 Support and the 200-day. A daily close below $322.83 or $320 is bearish (Stage 4 risk).
$334–338 Reclaim zone. Reclaiming it on volume is the first sign of repair.
$338.38 The 50-day SMA.
$359.8 The breakout pivot, far away.
$270–295 Long-term accumulation zone, if credit metrics are stable.

Macro triggers (from the macro analyst) - SPY closing below its 200-day. - VIX staying above VIX3M, or rising above 30. - HY spread moving toward 4.5pp. - The 10y–3m curve narrowing toward zero. - CPI above 4.1%.

What would turn the view bullish: SPY reclaiming its 50-day with VIX back in contango, plus CMF turning positive or JPM's RS line making new highs.

Risk-checked trade plans

Trade plans are illustrative and were risk-checked against a reference $10,000 model portfolio (0.5% risk per trade); any share counts refer to that model portfolio.

dayVWAP reclaim (long, mean reversion bounce off LOD)longrejected
Entry327.90
Stop325.40
Targets329.96, 330.09
Reward : risk0.82

Risk review: Hard violation: R:R to first target 0.82 vs minimum 1.5 (expectancy). The trading analyst also says JPM is not in play (RVOL 1.29, 6 VWAP crosses, midday chop). The stop-to-target math means a ~55-60% win rate is needed just to break even, and the market regime is not helping longs. PDT warning: the account is under $25k.

dayVWAP rejection (short)shortrejected
Entry326.30
Stop328.10
Targets325.61, 324.36
Reward : risk0.38

Risk review: Hard violation: R:R 0.38 vs minimum 1.5. Shorting at 326.3 into support at 325.61 leaves almost no room, and the bounce risk is real (RSI2 5.6, price above the 200 SMA 322.83). The short is also conditional on SPY weakness, which is not confirmed. PDT limits apply.

swingSpeculative RSI(2) mean-reversion bounce: close 327.06 > SMA200 322.83 and RSI2 5.6. Low quality: Trend Template 4/8, ADX 16.2, regime Yellow/Red (8 distribution days).longrejected
Entry331.00
Stop321.50
Targets334.35, 339.96
Reward : risk0.35

Risk review: Hard violation: R:R to first target 0.35 vs minimum 2.0. The final target gives only ~0.9R. The setup is low quality: Trend Template 4/8, ADX 16.2, regime Yellow/Red, and macro guidance is 'reduced' size. The stop is $9.50 (2.9%) away for a thin payoff, so the expected value is poor. Re-submit only with a better entry, for example a pullback to 324-325 that holds, or a reclaim of 334-338.

Analysis by discipline

▤Fundamentals & valuation neutral · 55

JPMorgan is a high-quality, diversified bank earning a ROE of 15.7% and trading at 2.47x book and 12.8x forward earnings. The price looks roughly fair against that return, with no clear margin of safety. DCF and EV metrics do not apply to a bank, so the valuation rests on P/B versus ROE. I would hold or add only on a pullback.

Key findings

  • Bank playbook applies: DCF and FCF are not meaningful (negative FCF of -147.8B reflects balance-sheet flows, not weak cash generation). dcf.applicable=false; FCF 2025 -147,782m; FCF yield -17%
  • Growth is solid and consistent. Revenue CAGR 12.5%; 2025 growth 7.32%; latest quarter yoy 8.06%
  • Profitability is strong, but net margin slipped from its 2024 peak. Net margin 34.5% (2024) to 31.4% (2025); ROE 15.7%; ROA 1.4%
  • Justified P/B is about 2.1x using ROE 15.7%, cost of equity 10.13% and an assumed g of 4%. That is below the current 2.47x. Using ROTCE, which is unknown and likely higher than ROE, would justify more. (0.157-0.04)/(0.1013-0.04)=1.91x; with g=5% it is 2.1x; P/B 2.47x
  • Multiples are reasonable but not cheap for a bank. P/E 13.7 trailing, 12.8 forward vs typical bank range of roughly 8-14x; PEG 1.4; dividend yield 2.02%, payout 26%
  • Capital return is steady, with shares shrinking and a low payout leaving room for buybacks. Diluted shares 2,970m to 2,781.5m (-6.35%); payout 26%

Risks

  • Credit cycle: rising provisions and net charge-offs, which are unknown in the data
  • Rate risk: the 10-year yield is 5.06% and the curve is positive at +0.92pp. Lower rates would compress NII
  • Net margin trending down from 34.5% to 31.4%
  • Multiple compression if ROTCE falls below the level the market assumes
  • Regulatory capital rules and market-sensitive investment banking revenue
⌕Accounting quality & events not_applicable · 55

JPM is a bank, so Beneish M, Altman Z and Piotroski F do not apply, and I do not score them. The SEC and event signals are routine: one officer/director 8-K, many 424B2 filings (typical of structured-note issuance by a large bank), and a steady record of earnings beats. Without credit-quality, reserve and capital data, I can't give a full forensic verdict, so I classify it as CLEAN on the available signals with low-to-moderate confidence.

Key findings

  • Standard forensic scores are not valid for banks FACTS note: Beneish, Altman and Piotroski are designed for non-financial firms. Cash flow, FCF and 'debt' for a bank are distorted by deposits and trading balances, so CFO vs net income tests are uninformative.
  • Negative FCF is not a red flag here FCF -147,782M in 2025 vs net margin 31.4%, FCF conversion -259%. For a bank this reflects balance-sheet growth and working-capital items in operating cash flow, not necessarily earnings manipulation. Treat as unreliable.
  • Goodwill is small Goodwill is 1.2% of assets, so there is little impairment risk from past acquisitions.
  • Net margin and share count are stable to improving Net margin 29.5%, 32.0%, 34.5%, 31.4% (2022-2025). Diluted shares fell from 2,970M to 2,781.5M, indicating buybacks rather than dilution.
  • 8-K Item 5.02 on 2026-11-17 needs a read Director/officer departure or appointment. There is no 4.01 (auditor change) or 4.02 (restatement) in the 90-day flags. The identity of the officer (e.g., a CFO) is unknown.
  • 'Possible share offering' flag is probably noise 12 424B2 filings dated 2026-11-18, with no S-3 or common-stock offering shown. Diluted shares have been falling. Likely structured notes or debt, but unverified.

Risks

  • Bank-specific risks (credit losses, reserves, capital ratios, P/TBV vs ROE) are not in the data (needed).
  • The 5.02 officer change could signal a CFO or senior risk departure; content is unknown.
  • Earnings-day gaps of about ±4% are possible; the 2.12% average is a guide, not a cap.
  • Fed funds rate changes and credit cycle shifts can hurt bank earnings regardless of accounting quality.
◍Macro, policy & credit neutral · 55

The macro backdrop is mixed to cautious for JPM. The market is in an uptrend under pressure (SPY -4.22% vs 50-day, +0.01% vs 200-day, 8 distribution days, VIX 25.48 in backwardation), and credit appetite is risk-off. Offsetting this, banks benefit from a positive curve (10y-3m +0.77pp) and a lagging-but-resilient financials sector (XLF +3.97 pts vs SPY over 3m). JPM itself has lagged XLF by 6.44 pts over 3m, and high inflation (CPI 4.08%) and 5%+ yields limit upside.

Key findings

  • Market regime is stressed: uptrend under pressure with institutional selling SPY -4.22% vs SMA50 and +0.01% vs SMA200; 8 distribution days in 25 sessions; QQQ -8.42% 1m
  • Volatility is elevated and the term structure signals stress VIX 25.48 vs VIX3M 25.0 (backwardation), VIX +47.2% 1m; implied daily S&P move 1.61%
  • Credit risk appetite is weak but not crisis-level HYG/LQD ratio -0.02% 1m (risk-off reading); HY spread 3.43pp, +0.14 1m. Spreads are widening slightly but are still moderate
  • Positively sloped curve supports bank net interest margin, but long yields are high 10y-3m +0.77pp (FRED) and +0.92pp (market); 10y 5.12%; 2y 4.83%. A steep, non-inverted curve is not a recession signal, though 5%+ 10y yields compress multiples
  • Inflation is high while the Fed is easing slightly, so the late-cycle risk is a hawkish surprise CPI yoy 4.08%; fed funds 3.88% (-0.21 over 12m); unemployment 4.1% (-0.3 over 12m). Policy rate below inflation suggests limited room to cut
  • Cycle reading is late-cycle, a mixed fit for financials Inflation 4.08%, tight labor market (4.1%), HY spread only 3.43pp. lists financials as early-cycle winners, but banks benefit when rates rise from low levels and the curve is positive

Risks

  • Further VIX spike and distribution-day accumulation could push SPY below its 200-day (currently +0.01%, a very thin cushion)
  • HY spreads widening from 3.43pp would raise credit-loss fears for banks
  • A hawkish Fed response to 4.08% CPI could raise yields further and compress valuations
  • Curve flattening or inversion would squeeze net interest margin
  • Risk-off in capital markets could hurt the investment banking and trading segments
⟋Technical analysis neutral · 55

JPM is in a short-term pullback inside a long-term base. Price of 327.06 is below the 10/21 EMA and 50 SMA, but still just above the rising 200 SMA (322.83). Momentum is oversold (RSI2 5.6, Stoch 9.2) while the weekly stage is only basing/topping and the market is under pressure. The best current setup is a speculative oversold bounce, not a clean trend trade, and it is low quality.

Key findings

  • Trend Template fails: only 4 of 8 checks pass. Price is below the 50 SMA and the RS line is not rising. Price 327.06 vs SMA50 338.38 (-3.34%); passed 4/8; price vs 150 SMA -1.48%
  • The long-term base holds. The 200 SMA is rising and price sits just above it, but the 150 SMA is overhead. SMA200 322.83 (+1.31% below price), 1m slope +1.0%; SMA150 331.96
  • The weekly stage is not Stage 2. Weinstein: Stage 1/3; close vs 10w -2.92%, vs 40w +1.2%; 30w MA slope +1.37%
  • Momentum is bearish on trend measures but deeply oversold short-term. MACD -0.781 vs signal 0.374, bearish cross; RSI14 40.1; RSI2 5.6; Stoch 9.2; %B -0.01; -DI 27.3 > +DI 20.8
  • There is no strong trend. A bounce is possible because the 200 SMA is still above the price's recent pullback support, but there's no confirmation yet. ADX 16.2 (<20); choppiness 46.6; ATR 7.25 (2.22%)
  • Volume shows distribution, not accumulation, though the last bar's volume was light. CMF20 -0.187; OBV falling; distribution days 5 vs accumulation 6; RVOL 0.32

Risks

  • A close below the 200 SMA (322.83) and support 324.36 would put JPM in Stage 4 and negate the mean-reversion setup.
  • SPY has 8 distribution days, so a broader selloff would drag JPM down.
  • Sector weakness (-6.44 pts) suggests group-wide selling.
  • A 5-day decline of -4.76% could signal a falling knife, and a fresh bearish MACD cross adds to that risk.
  • With a $10k account and $50 risk, ATR 7.25 means a small position size.
⇄Positioning & sentiment neutral · 55

Positioning in JPM is neutral to mildly soft. Short interest is tiny (0.9% of float) so there is no squeeze fuel, institutions are net adding, but insiders are only selling, volume indicators show mild distribution, and the price is weak (-4.76% over 5d) in a stressed market (VIX 25.48, backwardation). Options are not signalling panic: IV is cheap vs realized and put skew is modest.

Key findings

  • Short interest is negligible; no squeeze fuel and no heavy bearish crowd 0.9% of float, days to cover 3.36, change vs prior month -1.62%, squeeze risk low
  • Insiders: no open-market buying, only small sales; weak signal 0 buys, 3 sales worth $3.59M in 180d, 0 distinct buyers
  • Institutional ownership is high and top holders are mostly adding (13F lag ~45 days, so stale). Bank of America's -29.52% cut is notable but likely not a directional view Institutions 75.31%; top10 net adding 6; Vanguard Capital +7.7%, Vanguard Portfolio +7.28%, BlackRock -1.39%, BofA -29.52%
  • Volume shows mild distribution, matching the price pullback CMF20 -0.187, OBV 20d falling, distribution days 5 vs accumulation days 6, up/down volume 1.09; last bar rvol 0.32 (intraday, partial day, so not conclusive)
  • Options are calm and not pricing a large event. IV is cheap vs realized, skew shows modest hedging demand, and flow is balanced ATM IV 26.3% (30d) with iv_to_hv20 0.89; 30d expected move ±5.96% ($307.56-$346.56); 25d put-minus-call skew 4.1-4.9 pts; put/call volume 0.87-1.17, OI 0.92-1.24; no unusual activity
  • Analysts are split, with targets well above the price and no recent rating changes Targets: UBS Buy $400, Barclays OW $425, RBC Outperform $370, MS EW $377, Truist Hold $361, Citi Neutral $350 vs close $327.06; 0 upgrades, 0 downgrades

Risks

  • Outage and operational-risk headlines could trigger a further sell-off
  • Price is below a flat 30-week MA (Stage 1/3) with 10% drawdown from the 52-week high
  • Stressed market (VIX backwardation) can widen moves beyond the options-implied range
  • Cheap IV means that option buyers are not paying up, but realized volatility could still rise
  • Near-dated options (9 DTE) are thin: median spread 10.5% of mid, OI 231
⚡Trading plans

JPM is trading at 327.06 (12:28 ET), below VWAP 327.62 and close to the low of day 325.61. It has had 6 VWAP crosses and RVOL of 1.29, so this is a possible range day and the stock is not in play. Only low-conviction, small-size plays are justified. For swing trading, a speculative oversold-bounce long (RSI2 5.6) is possible, but the market regime is stressed, so the plan is tiny and conditional. The Donchian system is flat.

◇Options

JPM is at 327.06 in a short-term pullback inside a base. Direction is neutral-to-speculatively-bullish (oversold RSI2 5.6, but Trend Template 4/8, a stressed market with VIX 25.48 in backwardation, and weak flow). IV is cheap versus realized (IV/HV20 0.89) and there is no earnings event until 2027-01-14, so there is no IV-crush issue. The only structure that fits both the view and the $50 risk budget is a small, defined-risk 30 DTE bull call debit spread. Even that is above the budget by $220 (max loss $270 vs $50 per trade, $100 options cap), so it does not fit at 1 contract.

⛨Risk management

All three plans (day_1, day_2, swing) have hard violations in RISK_CHECKS (valid=false) because reward:risk is far below the minimums (0.82, 0.38 and 0.35). They must be rejected. The backdrop adds to the case: VIX 25.48 in backwardation, SPY below its 50-day with 8 distribution days, and a $10k account subject to PDT limits. The best action today is to stay flat and wait for a better setup.

Risks

  • Market stress: VIX 25.48 in backwardation (+47% in 1 month), SPY -4.22% vs its 50-day and only +0.01% above its 200-day. A close below the 200-day would shift to a downtrend regime.
  • Volatility: ATR14 is 2.22%, annual volatility 22.8%, 1-day VaR95 2.37% (about $237 on a $10k position), worst day -4.66%. The daily range is already 59% used.
  • Bank-specific data gaps: credit quality, reserves and capital ratios are unknown. The 8-K Item 5.02 officer change is unread, and outage headlines add operational risk.
  • Flow: CMF20 -0.187, OBV falling and mild distribution. Short interest is only 0.9%, so there is no squeeze fuel for longs and no squeeze risk for shorts.
  • Earnings 2027-01-14 are 57 days away, so there is no event gap risk in a typical swing hold. The average move is 2.12%, and one gap over 3% occurred in the last year.

Key data

Price$327.06
Market cap$868.54B
1M / 1Y return-2.45% / +10.98%
vs 52-week high-10.32%
Trend stageStage 1/3 - basing or topping (price below flat 30-week MA)
Trend Template4/8
RSI (14) / ADX40.1 / 16.2
ATR % of price2.22%
Support324.36, 305.97
Resistance334.35, 339.96
P/E (trailing / forward)13.7 / 12.8
EV / EBITDA—
FCF yield-17.01%
ROIC—
Net debt / EBITDA—
Street target (mean)$373.48
Next earnings2027-01-14
Avg earnings move2.12%
ATM implied vol27.4%
Options expected move3.83%
IV vs realizedcheap (IV below realized)
Short interest (float)0.90%
Market regimeuptrend under pressure (SPY below 50-day, above 200-day)
VIX / 10-yr yield25.48 / 5.06%

Figures are calculated from public market data at the time of the report and may be delayed or inaccurate.

Report details

Published
Prices and data as of
Data sourcesYahoo Finance · SEC EDGAR · FRED

Research methodology → · Disclaimer